Confocal laser endomicroscopy in the "in vivo" histological diagnosis of the gastrointestinal tract. by G. D.  De Palma
Giovanni D De Palma, Department of Surgery and Advanced 
Technologies, Center of Excellence for Technical Innovation in 
Surgery, University of Naples Federico II, School of Medicine, 
via Pansini 5, 80131 Naples, Italy
Author contributions: De Palma GD contributed solely to this 
paper.
Correspondence to: Giovanni D De Palma, MD, Department 
of Surgery and Advanced Technologies, Center of Excellence 
for Technical Innovation in Surgery, University of Naples 
Federico II, School of Medicine, via Pansini 5, 80131 Naples, 
Italy. giovanni.depalma@unina.it
Telephone: +39-81-7462773  Fax: +39-81-7462752
Received: August 12, 2009  Revised: November 6, 2009
Accepted: November 13, 2009
Published online: December 14, 2009 
Abstract
Recent technological advances in miniaturization 
have allowed for a confocal scanning microscope to 
be integrated into a conventional flexible endoscope, 
or into trans-endoscopic probes, a technique now 
known as confocal endomicroscopy or confocal laser 
endomicroscopy. This newly-developed technology 
has enabled endoscopists to collect real-time in 
vivo  histological images or “virtual biopsies” of the 
gastrointestinal mucosa during endoscopy, and has 
stimulated significant interest in the application of 
this technique in clinical gastroenterology. This review 
aims to evaluate the current data on the technical 
aspects and the utility of this new technology in 
clinical gastroenterology and its potential impact in the 
future, particularly in the screening or surveillance of 
gastrointestinal neoplasia.
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INTRODUCTION
In recent years, endoscopic image quality has improved 
as the devices have advanced technologically. Although 
techniques such as chromoendoscopy, high resolution 
and magnification endoscopy, narrow band imaging, 
and auto-fluorescence imaging improve the visualization 
and detection of  mucosal lesions, biopsy of  the targeted 
lesion must still be performed for a formal histological 
diagnosis of  cellular and architectural atypia.
Suspicious areas identified during endoscopy are 
targeted and biopsied or removed endoscopically. 
However, there are several disadvantages that may 
be associated with biopsies or endoscopic resection, 
including bleeding or perforation. Non-representative 
biopsies may miss relevant portions of  tissue, leading 
to underestimation of  the diagnosis. Random biopsy 
sampling or endoscopic resection for non-neoplastic 
lesions can also be time-consuming. It would be ideal 
if  a definite diagnosis could be made during endoscopy 
without a biopsy.
Recent technological advances in miniaturization 
have allowed for a confocal scanning microscope to 
be integrated into a conventional flexible endoscope, 
or into trans-endoscopic probes, a technique now 
known as confocal endomicroscopy (CEM) or confocal 
laser endomicroscopy (CLE). This newly-developed 
technology has enabled endoscopists to collect real-time 
in vivo histological images or “virtual biopsies” of  the 
gastrointestinal (GI) mucosa during endoscopy, and has 
stimulated significant interest in the application of  this 
technique in clinical gastroenterology[1-8].
This report aims to evaluate the current data on the 
utility of  this new technology in clinical gastroenterology 
and its potential impact in the future, particularly in the 
screening or surveillance of  GI neoplasia.
PRINCIPLES OF CONFOCAL MICROSCOPY
Confocal microscopy has been used in the biological sci-
ences since 1961 when the concept of  optical sectioning 
of  a biological specimen was introduced.
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To create confocal images, a low-powered laser (an 
argon-ion laser that generates an excitation wavelength 
of  488 nm, blue laser light) is focused by an objective 
lens into a single point, within a fluorescent specimen. 
The same lens is used as both the condenser and objec-
tive folding. The point of  illumination thus coincides 
with the point of  detection within the specimen. Light 
emanating from that point is focused through a pinhole 
to a detector, and light emanating from outside the il-
luminated spot is rejected. The illumination and detec-
tion systems are in the same focal plane and are termed 
“confocal” (Figure 1). 
After passing the pinhole, the fluorescent light is 
detected by a photodetection device (a photomultiplier 
tube or avalanche photodiode), transforming the light 
signal into an electrical one that is recorded by a com-
puter. All detected signals from the illuminated spot are 
captured and measured.
As the laser scans over the plane of  interest, a whole 
image is obtained pixel-by-pixel and line-by-line, whereas 
the brightness of  a resulting image pixel corresponds to 
the relative intensity of  detected fluorescent light.
The gray-scale image created is an optical section 
representing one focal plane within the examined speci-
men. 
Confocal microscopy provides the capacity for direct, 
non-invasive, serial optical sectioning of  intact, thick, 
living specimens with a minimum of  sample preparation 
as well as a marginal improvement in lateral resolution. 
Because confocal images depend on fluorescence, a fluo-
rescent dye (contrast agent) is required to make objects 
visible.
CONTRAST AGENTS 
A fluorescent contrast agent is used and is needed to 
achieve high contrast images using CEM. Potentially 
suitable agents in humans are fluorescein, acriflavine, tet-
racycline or cresyl violet. The contrast agents can be ap-
plied systemically (fluorescein, tetracycline) or topically 
(acriflavine, cresyl violet) by using a spraying catheter. 
Of  these, intravenous fluorescein sodium (10%) and 
topically applied acriflavine (0.2%) have been most com-
monly used in humans. No data is so far available on the 
use of  tetracycline and cresyl violet.
Fluorescein is an agent used for diagnostic fluorescein 
angiography or angioscopy of  the retina and iris vascu-
lature.
After intravenous injection, fluorescein binds ext-
ensively to serum albumin in the bloodstream. The 
unbound contrast diffuses across capillaries, entering the 
tissue and staining the extracellular matrix of  the surface 
epithelium and the lamina propria for up to 30 min[9]. 
Cell nuclei and mucin are not stained by fluorescein and 
therefore appear dark. The mucosal structures that can 
be identified after fluorescein administration include 
enterocytes, cellular infiltrate, surface epithelial cells, 
blood vessels, and red blood cells. Fluorescein is a highly 
safe agent whose major side effects are short term (1-2 h) 
and include yellowish skin discoloration and 1-2 d 
of  bright yellow-colored urine. Nausea and vomiting 
were reported during angiography and were transient 
and minor. Serious side effects, such as anaphylaxis or 
cardiac or respiratory effects, are extremely rare, and to 
date, have not been recorded in CEM.
Topical acriflavine is highly specific for labeling acidic 
constituents, and stains the nuclei of  superficial layers 
of  the mucosa. The staining provides clear visualization 
of  cell nuclei in the uppermost mucosa and may allow 
better differentiation between intra-epithelial neoplasia 
and cancer of  the GI tract. Although there has been 
a hypothetical concern about the risk of  mutagenesis, 
no severe adverse reactions have been reported after 
the topical use of  acriflavine. However, concerns about 
DNA damage by acriflavine stain have reduced its use in 
humans.
Fluorescein and acriflavine can also be used simult-
aneously which adds to the labeling properties.
EQUIPMENT 
CLE can be performed currently with 2 devices: (1) in-
tegrated into an endoscope (Pentax, Tokio, Japan, herein 
termed eCLE); and (2) as a stand-alone probe (herein 
termed pCLE) capable of  passage through the acces-
sory channel of  most endoscopes (Cellvizio, Mauna Kea 
Technologies, Paris, France)[10-14].
The Pentax EG-3870CIK (upper endoscope) and EC-
3870CILK (colonoscope)
The components of  the confocal laser endoscope are 
based on the integration of  a confocal laser microscope 
in the distal tip of  a conventional video endoscope, which 
enables confocal microscopy in addition to standard 
video endoscopy (Figure 2). The diameter of  both the 
distal tip and the insertion tube is 12.8 mm. The distal 
tip contains an air and water jet nozzle, 2 light guides, an 
auxiliary water jet channel (used for topical application 
of  the contrast agent) and a 2.8 mm working channel. 
This imaging system provides confocal imaging using 
an incident 488 nm wavelength laser, and enables the 
detection of  fluorescence of  505-585 nm wavelength, 
with reduced image noise compared with the reflectance 
confocal systems. CLE imaging data are collected at a scan 
rate of  rate of  1.6 frames per second (1024 × 512 pixels) 
or 0.8 frames per second (1024 × 1024 pixels) with an 
adjustable depth of  scanning ranging from 0 to 250 μm, a 
field of  view of  475 μm × 475 μm, a lateral resolution of  
0.7 μm, and an axial resolution of  7 μm. Confocal images 
are generated simultaneously with the endoscopic images 
and the endoscope working channel can still be used.
The Cellvizio® endomicroscopy system
The Cellvizio® Endomicroscopy System (Figure 3) is 
based on a different catheter probe with a semiconductor 
laser that oscillates at 488 nm. The latest model of  
Cellvizio confocal miniprobes created for GI tract 
applications include CholangioFlex, GastroFlex, ColoFlex, 
GastroFlex-UHD, and ColoFlex-UHD. CholangioFlex 
probes designed for use during endoscopic retrograde 
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cholangiopancreatography require an endoscope accessory 
channel of  at least 1.2 mm, whereas the other probes, 
which are designed for use in esophagogastroduodenosco
py and colonoscopy, require a channel larger than 2.8 mm. 
All probes generate dynamic (12 frames per second) 
images with a scanning field of  30 000 pixels. 
This system has a field of  view of  240-600 μm 
(CholangioFlex probes: 325 μm; GastroFlex and 
ColoFlex: 600 μm; GastroFlex-UHD and ColoFlex-
UHD: 240 μm) with a lateral resolution of  1-3.5 μm (the 
lateral resolution for CholangioFlex and for GastroFlex 
and ColoFlex probes is 3.5 μm; the lateral resolution for 
GastroFlex-UHD and ColoFlex-UHD is 1 μm). This 
system has a fixed imaging plane depth, and different 
confocal miniprobes are required to vary the depth of  
imaging. The depth of  imaging for CholangioFlex probes 
is 40-70 μm, 70-130 μm for GastroFlex and ColoFlex), 
and 55-65 μm for GastroFlex-UHD and ColoFlex-UHD.
Single video frames are reconstructed by a special 
computer algorithm (‘‘mosaicing’’) in an image with an 
enlarged field of  view (4 mm × 2 mm). 
PROCEDURE
Once a suspicious area of  the mucosa is identified, 
contrast agents (fluorescein and/or acriflavine) can be 
given, and a CEM examination of  the targeted area is 
performed by placing the distal tip of  the endoscope or 
the distal tip of  the catheter probe against the targeted 
mucosa. Gentle suction and/or an endoscopic cap can be 
used to stabilize the equipment and minimize excessive 
movement, which is important to reduce movement 
artifacts during imaging. At the area of  interest, images 
can be obtained using an image-capture foot pedal and 
stored digitally.
INTERPRETATION OF CLE IMAGES
The orientation of  the “cut” plane of  confocal in vivo 
histological images is horizontal whereas in conventional 
histological specimens it is longitudinal. CLE images 
cannot display a simultaneous overview of  the mucosal 
and submucosal structures, unlike conventional 
histology. CLE images provide a thorough view of  the 
mucosal architecture and allow rapid differentiation 
between normal, regenerative, and neoplastic mucosa 
of  the GI tract. Differentiation between grades of  intra-
epithelial neoplasm by CEM, however, is not yet possible 
with the currently available staining techniques.
Endoscopists who perform CEM require a funda-
mental knowledge of  the normal and disease micro-
architecture of  the GI tract. An onsite pathologist or at 
least a review of  the stored images by a pathologist and 
correlation with biopsy histology is recommended dur-
ing the learning process.
Some studies of  the learning curve for CLE per-
formed by endoscopists demonstrates that highly ac-
curate, efficient in vivo prediction of  Barrett’s esophagus 
can be achieved after approximately 20-30 independently 
performed CLE procedures.
Normal and pathological aspects of  CLE imaging 
of  the upper and lower GI tract are shown in Tables 1-3 
and Figures 3-5.
CLINICAL DATA
The current potential indications for CLE imaging are 
www.wjgnet.com
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Figure 1  Schematic of confocal endomicroscopy principles.
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Figure 2  The endoscope-based confocal laser endomicroscopy (eCLE) 
imaging system: the distal tip.
Figure 3  The probe-based CLE (pCLE) imaging system.
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broad and include almost all current applications of  
endoscopic biopsy. 
Unequivocally, this technology is best used in 
conjunction with other “red-flag” techniques because 
of  its minute scanning area, and thus is only appropriate 
for classification of  tissue at a site already detected 
by standard or optically enhanced endoscopy. Ideally, 
the no-dye “red-flag” techniques such as narrow band 
imaging or auto-fluorescence imaging, should be used 
to screen the mucosa for “areas of  interest”, which 
can then be interrogated by CEM for a “histological” 
diagnosis. An example would be use of  narrow-band 
imaging to detect regions of  suspicion in Barrett’s 
esophagus, followed by CLE to confirm intraepithelial 
neoplasia, and guide immediate therapy.
The confocal laser endoscope can be used routinely 
for screening and surveillance. Suspicious lesions 
can be examined in a targeted fashion by placing the 
endomicroscopy window onto the lesion. Confocal 
images can be graduated according to cellular and vascular 
changes. The images correlate well with conventional 
histology after targeted biopsies.
Numerous studies have addressed the clinical appli-
cations of  CLE, in particular in the study of  precancerous 
lesions of  the upper and lower GI tract[15,16]. 
In patients with Barrett’s esophagus, CLE can 
diagnose Barrett’s epithelium and Barrett’s-associated 
neoplastic changes with an accuracy > 90% for both 
e-CLE or p-CLE[17-23].
CLE in the stomach allows good visualization of  
normal and pathologic gastric pit patterns, making it a 
potentially useful tool for diagnosis of  gastric cancer and 
precancerous conditions. Direct in vivo identification of  
Helicobacter pylori infection can be obtained[24-27].
In patients with suspected celiac disease, confocal 
endomicroscopy can demonstrate villous atrophy and 
an increased number of  intraepithelial lymphocytes, 
enabling immediate in vivo diagnosis of  celiac disease[28].
The presence of  neoplastic changes in a colonic 
mucosa can be predict with high accuracy (> 95%). 
CLE has several potential roles in polyp management. 
The best-studied application is to distinguish between 
hyperplastic and adenomatous polyps, thus negating 
the need to remove hyperplastic polyps. In patients 
with long-term ulcerative colitis, chromoscopy with 
supplemental CEM, has recently been shown to further 
increase the yield for intraepithelial neoplasia above and 
beyond methylene blue. pCLE also has the capacity 
www.wjgnet.com
Table 1  Confocal criteria for squamous cell epithelium and carcinoma
Squamous cell epithelium Squamous cell neoplasia
Cellular criteria Dark, homogeneous epithelial cells; regular architecture and 
clearly visible borders
Dark cells with different sizes; no clearly visible borders; 
irregular architecture
Vascular criteria Capillaries directed to luminal epithelium without leakage of 
fluorescein
Twisted and irregular vessels; elongated capillaries; capillary 
leakage
Table 2  CLE classification of Barrett’s esophagus
Confocal diagnosis Vessel architecture Crypt architecture
Gastric-type 
epithelium
Capillaries with a regular shape only visible in the deeper parts 
of the mucosal layer
Regular columnar-lined epithelium with round glandular 
openings and typical cobblestone appearance
Barrett’s epithelium Subepithelial capillaries with a regular shape underneath 
columnar-lined epithelium visible in the upper and deeper parts 
of the mucosal layer
Columnar-lined epithelium with intermittent dark mucin 
in goblet cells in the upper parts of the mucosal layer. In 
the deeper parts, villous, dark, regular cylindrical Barrett’s 
epithelial cells are present
Neoplasia Irregular capillaries visible in the upper and deeper parts of the 
mucosal layer. Leakage of vessels leads to a heterogeneous and 
brighter signal intensity within the lamina propria
Black cells with irregular apical and distal borders and 
shapes, with strong dark contrast against the surrounding 
tissue
Table 3  CLE classification of patterns in colorectal lesions
Grading Vessel architecture Crypt architecture
Normal Hexagonal, honeycomb appearance that presents a network of 
capillaries outlining the stroma surrounding the luminal openings 
of the crypts
Regular luminal openings and distribution of crypts covered 
by a homogeneous layer of epithelial cells, including goblet 
cells
Regeneration Hexagonal, honeycomb appearance with no increase or only a 
slight increase in the number of capillaries
Star-shaped luminal crypt openings or focal aggregation of 
regular-shaped crypts with a regular or reduced amount of 
goblet cells
Neoplasia Dilated and distorted vessels with increased leakage; irregular 
architecture, with little or no orientation to the adjoining tissue
Ridge-lined irregular epithelial layer with loss of crypts 
and goblet cells; irregular cell architecture, with little or no 
mucin
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to differentiate normal from inflamed tissue, and thus 
target biopsies for the purpose of  grading and mapping 
the extent of  colitis[29-34].
CEM can also be helpful for the diagnosis of  micro-
scopic colitis in patients with chronic diarrhea. In 
patients with collagenous colitis, it allows direct in vivo 
visualization of  collagenous bands under the epithelial 
layer of  the colon, and in patients with lymphocytic 
colitis, it can demonstrate crypt distortion and an 
increased distance between the colonic crypt. Thus, CLE 
has the potential to replace or direct a large number of  
random biopsies in patients with chronic diarrhea, where 
the confocal image is normal[35-37].
Pancreato-biliary applications are under way using 
the probe-based CLE. The major role of  pCLE in the 
bile duct is likely to detect cancer in indeterminate bile 
duct and pancreatic strictures[38,39]. 
CONCLUSION
CLE is a rapidly emerging field of  gastroenterology that 
bridges the interface between endoscopy and histology. 
It further expands our ability to image living tissue in 
real time and to provide therapy in the same setting. The 
immediate impact will be the ability to target biopsies 
much more precisely, and eliminate a large number 
of  random biopsies. Currently available devices for 
CEM have a very narrow field of  view and allow only 
visualization of  the superficial mucosal layer of  the GI 
tract. Further technological developments are needed to 
enlarge the field of  view, which will facilitate the use of  
CEM for cancer screening and surveillance. Increased 
depth of  penetration is also needed to assess depth of  
invasion during cancer staging. 
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